Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

431 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase II study.
Carlomagno C, Farella A, Bucci L, D'Armiento FP, Pesce G, Pepe S, Cannella L, Pacelli R, De Stefano A, Solla R, D'Armiento MR, De Placido S. Carlomagno C, et al. Among authors: de stefano a, de placido s. Ann Oncol. 2009 May;20(5):906-12. doi: 10.1093/annonc/mdn719. Epub 2009 Jan 20. Ann Oncol. 2009. PMID: 19155242 Free article. Clinical Trial.
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Della Vittoria Scarpati G, Falcetta F, Carlomagno C, Ubezio P, Marchini S, De Stefano A, Singh VK, D'Incalci M, De Placido S, Pepe S. Della Vittoria Scarpati G, et al. Among authors: de stefano a, de placido s. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1113-9. doi: 10.1016/j.ijrobp.2011.09.030. Epub 2011 Dec 13. Int J Radiat Oncol Biol Phys. 2012. PMID: 22172905
Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom?
De Stefano A, Moretto R, Bucci L, Pepe S, Romano FJ, Cella AC, Attademo L, Rosanova M, De Falco S, Fiore G, Raimondo L, De Placido S, Carlomagno C. De Stefano A, et al. Among authors: de placido s, de falco s. Clin Colorectal Cancer. 2014 Sep;13(3):185-91. doi: 10.1016/j.clcc.2014.05.004. Epub 2014 Jun 26. Clin Colorectal Cancer. 2014. PMID: 25080847
Multiple treatment lines and prognosis in metastatic colorectal cancer patients.
Carlomagno C, De Stefano A, Rosanova M, De Falco S, Attademo L, Fiore G, De Placido S. Carlomagno C, et al. Among authors: de stefano a, de placido s, de falco s. Cancer Metastasis Rev. 2019 Jun;38(1-2):307-313. doi: 10.1007/s10555-018-9748-7. Cancer Metastasis Rev. 2019. PMID: 30003458
KRAS mutation detection by high-resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer.
Malapelle U, Carlomagno C, Salatiello M, De Stefano A, De Luca C, Bianco R, Marciano R, Cimminiello C, Bellevicine C, De Placido S, Troncone G. Malapelle U, et al. Among authors: de stefano a, de placido s, de luca c. Br J Cancer. 2012 Aug 7;107(4):626-31. doi: 10.1038/bjc.2012.275. Epub 2012 Jul 17. Br J Cancer. 2012. PMID: 22805329 Free PMC article.
Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II study.
Di Lorenzo G, Rea A, Carlomagno C, Pepe S, Palmieri G, Labianca R, Chirianni A, De Stefano A, Esposito V, De Placido S, Montesarchio V. Di Lorenzo G, et al. Among authors: de stefano a, de placido s. World J Gastroenterol. 2007 Dec 28;13(48):6553-7. doi: 10.3748/wjg.v13.i48.6553. World J Gastroenterol. 2007. PMID: 18161926 Free PMC article. Clinical Trial.
431 results